PIRS under the radar and extremely undervalued. Several collaborations with BP, the latest of which comes with an up front payment equal to half of the market cap. Time to accumulate before takeoff.
(0)
(0)
Pieris Pharmaceuticals, Inc. (PIRS) Stock Research Links
